BTX: Why The June Tender Offer Keeps This A 'Buy'

An analyst reiterates a "Buy" rating on BlackRock Technology and Private Equity Term Trust (BTX), citing an upcoming June tender offer at 99.5% of NAV as a low-risk exit opportunity. While the fund's discount to NAV has narrowed, the tender offer could unlock further value, particularly if PsiQuantum's valuation round closes. Post-tender, BTX's strategy shift to unlimited private tech investments increases risk but also potential upside contingent on private valuation improvements, making BTX still worth a buy.

Analysis

The BlackRock Technology and Private Equity Term Trust (BTX), a closed-end fund with over $1.5 billion in Assets Under Management (AUM) and a notable double-digit distribution rate, has received a reiterated "BUY" recommendation. This positive outlook is primarily anchored by an upcoming June tender offer, which will allow shareholders to tender shares at 99.5% of Net Asset Value (NAV), presenting what is described as a low-risk exit opportunity. Although the fund's discount to NAV has narrowed, the tender offer itself is positioned as a mechanism to potentially unlock further value. A significant near-term catalyst highlighted is the potential closure of PsiQuantum's valuation round, which could positively impact BTX's NAV and further enhance returns through the tender. Post-tender, BTX is set to undergo a strategic shift towards unlimited private technology investments; this change introduces a higher risk profile but concurrently offers increased upside potential, particularly contingent on an improvement in private market valuations. The analyst reiterating the buy rating maintains a beneficial long position in BTX.

Key Decisions for Investors

• Investors should evaluate the upcoming June tender offer for BTX as an opportunity to realize value at 99.5% of NAV, potentially offering a low-risk exit or partial realization of gains.
• Consideration of holding BTX post-tender involves weighing the increased risk from unlimited private technology investments against the potential for higher returns, especially if private market valuations improve and PsiQuantum's valuation materializes favorably.
• Monitoring the outcome of PsiQuantum's valuation round and the evolving conditions within the private technology investment landscape will be critical for assessing BTX's attractiveness after the tender offer concludes.